Citigroup Adjusts Gilead Sciences PT to $165 From $156, Maintains Buy Rating
Gilead Sciences (GILD) has an average rating of overweight and mean price target of $160.44, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $138.65, Change: $-0.38, Percent Change: -0.27%